NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising. - podcast episode cover

NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising.

Sep 16, 20158 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Christopher Robertson is a professor at the James E. Rogers College of Law at the University of Arizona. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.T. Robertson. New DTCA Guidance - Enough to Empower Consumers? N Engl J Med 2015;373:1085-7. J.A. Greene and E.S. Watkins. The Vernacular of Risk - Rethinking Direct-to-Consumer Advertising of Pharmaceuticals. N Engl J Med 2015;373:1087-9.
For the best experience, listen in Metacast app for iOS or Android